TY - JOUR
T1 - Evidence-based management of heart failure in clinical practice
T2 - A review of device-based therapy use
AU - Thavapalachandran, S.
AU - Leong, D. P.
AU - Stiles, M. K.
AU - John, B.
AU - Dimitri, H.
AU - Lau, D. H.
AU - Psaltis, P. J.
AU - Brooks, A. G.
AU - Alasady, M.
AU - Lim, H. S.
AU - Young, G. D.
AU - Sanders, P.
PY - 2009/10/1
Y1 - 2009/10/1
N2 - Background: Heart failure is a growing health issue and is associated with significant mortality risk. Device therapy is efficacious in preventing sudden death in patients with heart failure; however, this evidence comes from rigorous clinical trials. It is unclear how device therapy is utilized in 'real-world' practice. The primary objective was to characterize patterns of device use in patients with heart failure at risk of sudden death and to identify barriers to guideline-driven prescription of implantable cardioverter-defibrillators. Methods: We report a cross-sectional study of patients attending general cardiology clinic over a 3-month period. Results: Of 1003 consecutive patients attending the cardiology clinic, 176 had heart failure. Of these, 66 were potentially eligible for device therapy, but only 16 of these had actually undergone device implantation. Potentially eligible non-recipients were older (P < 0.001), more likely to have ischaemic cardiomyopathy (P = 0.002), less likely to be prescribed spironolactone (P = 0.005) or warfarin (P = 0.02), and less likely to have a widened QRS > 120 ms (P = 0.005). There was a high prevalence of underuse of evidence-based pharmacotherapies among patients with heart failure. Conclusion: There is substantial underuse of device therapy in patients with heart failure. Strikingly, whereas patients with symptoms of heart failure were more likely to receive a device, those being managed for ischaemic heart disease were not. There is also a high prevalence of failure to prescribe evidence-based pharmacotherapy in a tertiary hospital general cardiology clinic. This may be explained in part by the lack of a patient database to record treatment contraindications and to alert clinicians to possible gaps in patient therapy.
AB - Background: Heart failure is a growing health issue and is associated with significant mortality risk. Device therapy is efficacious in preventing sudden death in patients with heart failure; however, this evidence comes from rigorous clinical trials. It is unclear how device therapy is utilized in 'real-world' practice. The primary objective was to characterize patterns of device use in patients with heart failure at risk of sudden death and to identify barriers to guideline-driven prescription of implantable cardioverter-defibrillators. Methods: We report a cross-sectional study of patients attending general cardiology clinic over a 3-month period. Results: Of 1003 consecutive patients attending the cardiology clinic, 176 had heart failure. Of these, 66 were potentially eligible for device therapy, but only 16 of these had actually undergone device implantation. Potentially eligible non-recipients were older (P < 0.001), more likely to have ischaemic cardiomyopathy (P = 0.002), less likely to be prescribed spironolactone (P = 0.005) or warfarin (P = 0.02), and less likely to have a widened QRS > 120 ms (P = 0.005). There was a high prevalence of underuse of evidence-based pharmacotherapies among patients with heart failure. Conclusion: There is substantial underuse of device therapy in patients with heart failure. Strikingly, whereas patients with symptoms of heart failure were more likely to receive a device, those being managed for ischaemic heart disease were not. There is also a high prevalence of failure to prescribe evidence-based pharmacotherapy in a tertiary hospital general cardiology clinic. This may be explained in part by the lack of a patient database to record treatment contraindications and to alert clinicians to possible gaps in patient therapy.
KW - Heart failure
KW - Implantable cardioverter-defibrillator
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=70350116086&partnerID=8YFLogxK
U2 - 10.1111/j.1445-5994.2008.01876.x
DO - 10.1111/j.1445-5994.2008.01876.x
M3 - Article
C2 - 19849757
AN - SCOPUS:70350116086
SN - 1444-0903
VL - 39
SP - 669
EP - 675
JO - Internal Medicine Journal
JF - Internal Medicine Journal
IS - 10
ER -